Zurueck zur Suche

Reporte zur Charge U8192AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

14Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 3 MA 2 WA 2 CA 2 OR 1 MT 1 AK 1 IN 1 NV 1

VAERS 2721771

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

schwer
Staat
OR
Alter
11,0
Geschlecht
F
Eingang
07.12.2023
Impfdatum
06.12.2023
Beginn
06.12.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Loss of consciousness Pallor Staring Urinary incontinence

Symptomtext

CMA administered the above vaccinations to this patient while she was sitting in a chair. Two minutes after the injections, patient had a blank stare and then had LOC for a couple seconds. CMA assisted patient to the floor safely during this. Patient urinated herself. CMA yelled out for help from the triage nurse's. RN and LPN came to the exam room. Patient is pale and diaphoretic but A&O now. Assisted patient to lay down on the floor with a pillow under her head. Vitals were taken and documented. Patent was monitored. After she was feeling better, we had her sit up and drink an apple juice box. Patient declined crackers. Patient then was able to get back into the chair. Patient was given pants to change into. Dr (pcp) was notified and came into the exam room to evaluate patient. Vitals were checked again. Patient was feeling better and ambulated out of the clinic with her mother. (Patient was fasting and very anxious prior to these vaccinations.)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
Retin A cream and Tylenol PRN
Allergien
peanuts
Vorherige Impfungen
-

VAERS 2709499

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

moderat
Staat
NC
Alter
37,0
Geschlecht
F
Eingang
03.11.2023
Impfdatum
02.11.2023
Beginn
02.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dyspnoea Electrocardiogram Erythema Flushing Paraesthesia

Symptomtext

Within 30 minutes of vaccine administration she became very flushed, short of breath, tingling all over, she has some redness on her skin, no sensation of her lips or tongue swelling. She states similar to her anaphylactic reactions in the past.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Vital signs recorded EKG
Aktuelle Erkrankungen
None
Vorgeschichte
Hiatal Hernia Cystitis Hysterectomy- pre cancerous cell/heavy periods
Andere Medikamente
Vyvanse 50mg PO daily
Allergien
promethazine HCL (Phenergan) Fioricet Covid vaccine allergy (now) flu vaccine allergy
Vorherige Impfungen
COVID Vaccine (Pfizer)

VAERS 2724148

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
MT
Alter
62,0
Geschlecht
M
Eingang
14.12.2023
Impfdatum
25.10.2023
Beginn
25.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Malaise Myalgia

Symptomtext

After receiving vaccinations, patient has had long-term, persistent malaise, muscle ache, fatigue, and mild headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Asthma
Andere Medikamente
Advair 250/50, allopurinol 300mg, trazodone 50mg
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2720428

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
MA
Alter
47,0
Geschlecht
M
Eingang
04.12.2023
Impfdatum
13.11.2023
Beginn
14.11.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia

Symptomtext

joint pain sometimes extreme; Initial information received on 24-Nov-2023 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 47-year-old male patient who had joint pain sometimes extreme after receiving influenza quadrival A-B vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 13-Nov-2023, the patient received an 0.5 ml dose of suspect influenza quadrival A-B vaccine, Suspension for injection (strength, expiry date: unknown) (lot: U8192AA) via intramuscular route in the left upper arm for Influenza (influenza immunization) On 14-Nov-2023 the patient had an event of joint pain sometimes extreme (arthralgia) (latency: 1 day) following the administration of influenza quadrival A-B vaccine. Reportedly, Joint pain sometimes extreme. Would go away after a few minutes. Some Joint pain seems to be lingering but not as severe. It was unknown if any lab data/test results available. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. Outcome: Recovering / Resolving for the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2719566

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
WA
Alter
30,0
Geschlecht
F
Eingang
30.11.2023
Impfdatum
18.11.2023
Beginn
19.11.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Fatigue Myalgia

Symptomtext

The patient received a second dose of Fluzone vaccine on the same day. In the next 24 hours the patient reported significant fatigue and myalgias, which resolved approximately after 24 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none known
Vorgeschichte
Tolosa-Hunt Syndrome ADHD
Andere Medikamente
Methylphenidate 27mg/day
Allergien
Naproxen = difficulty breathing
Vorherige Impfungen
-

VAERS 2719342

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
WA
Alter
30,0
Geschlecht
F
Eingang
30.11.2023
Impfdatum
17.11.2023
Beginn
17.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Pain

Symptomtext

body ache; administered with 2 doses of fluzone qiv np on both arms, 5 minutes apart with no reported adverse event; Initial information received on 22-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 30-year-old female patient who was administered with 2 doses of influenza quadrival A-B vaccine [Fluzone QIV] on both arms, 5 minutes apart with no reported adverse event and had body ache. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included polio vaccine for Prophylactic vaccination. On 17-Nov-2023, the patient received 0.5 ml dose of suspect influenza quadrival A-B vaccine, Suspension for injection (strength, expiry date: unknown) (lot: U8192AA) via intramuscular route in left and right deltoid for Immunization and administered with 2 doses of fluzone qiv np on both arms, 5 minutes apart with no reported adverse event (extra dose administered) (latency: same day) On 19-Nov-2023 the patient had an event of body ache (pain) (latency: 2 days) following the administration of influenza quadrival A-B vaccine. It was unknown if any lab data/test results available. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. Outcome: Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
POLIO VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2719096

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
AK
Alter
45,0
Geschlecht
F
Eingang
29.11.2023
Impfdatum
01.11.2023
Beginn
02.11.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site swelling Vomiting

Symptomtext

"Pt reports R arm redness and swelling noted starting this morning. Also notes they had some vomiting yesterday following appointment and this morning, as well. They had the same issue with a shingles vaccine they received from Walmart 4-5 years ago. Reports 3/4 inch area of redness and swelling at injection site. This nurse recommended OTC Benadryl and increased monitoring of symptoms. Pt verbalizes understanding of symptoms concerning for ED visit."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Ulcerative Colitis
Vorgeschichte
Past Medical History: ? Acid reflux disease ? Anxiety ? Asthma ? Bipolar disorder (HCC) ? Chronic back pain Lower as well as neck ? Claustrophobia "O2 mask is ok" ? Closed displaced fracture of medial malleolus of right tibia 6/22/2018 ? Crohn's disease (HCC) ? Depression ? Difficult intravenous access ? Disc disorder ? Dizzy spells ? Endometriosis ? Family history of colon cancer Paternal grandfather ? Head injury "Concussion as a child" ? Hyperlipidemia ? Hypertension ? IBS (irritable bowel syndrome) ? Kidney stone ? Legally blind per patient 1/23/20 ? Migraines ? Pain management contract agreement ? Panic attacks ? PONV (postoperative nausea and vomiting) ? PTSD (post-traumatic stress disorder) ? Pustular psoriasis of palms and soles ? Range of motion deficit ? Seizures (HCC) 03/20/19: last seizure was in 06/2018 ? Sleep apnea using CPAP ? Syncope and collapse ? Ulcerative (chronic) enterocolitis (HCC)
Andere Medikamente
albuterol 1.25 mg/3 mL nebulizer solution 1 ampule, Nebulization, EVERY 6 HOURS PRN ? albuterol-ipratropium (COMBIVENT RESPIMAT) 100-20 mcg/puff inhaler INHALE 1 PUFF BY MOUTH EVERY 6 HOURS AS NEEDED ? amoxicillin-clavulanate (AUGMENTIN) 8
Allergien
? Zoster Vac Recomb Adjuvanted Dermatitis ? Ethosuximide Rash ? Gabapentin Hives ? Hydrochlorothiazide Rash ? Hydromorphone Nausea And Vomiting Paroxetine Rash ? Sulfamethoxazole-Trimethoprim Hives
Vorherige Impfungen
Shingles vaccine from Pharmacy 4-5 years ago. Reports 3/4 inch area of redness and swelling at injection site.

VAERS 2693288

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
CA
Alter
51,0
Geschlecht
M
Eingang
10.10.2023
Impfdatum
09.10.2023
Beginn
09.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Injection site erythema Injection site pain Injection site warmth

Symptomtext

-Pain described as "hot oil" during plunger depression -Red lines coming from injection site -Patient cried out in pain -Reaction for Shingrix ONLY, Not flu -Shingrix given 0.3ML L delt, IM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2692772

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
MA
Alter
29,0
Geschlecht
F
Eingang
09.10.2023
Impfdatum
07.10.2023
Beginn
07.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Redness, swelling, itching, pain at injection site, covering entire deltoid

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
IBS-M, Ehlers-Danlos Syndrome hypermobile type, postural orthostatic tachycardia syndrome
Andere Medikamente
Buspirone, escitalopram, propranolol, vitamin D, iron, levocarnitine, daily prenatal vitamin
Allergien
Aviane, cilantro, coriander
Vorherige Impfungen
-

VAERS 2692721

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

mild
Staat
IN
Alter
60,0
Geschlecht
F
Eingang
09.10.2023
Impfdatum
03.10.2023
Beginn
04.10.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site pain

Symptomtext

Severe pain at the site of injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2715890

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

gering
Staat
CA
Alter
1,2
Geschlecht
U
Eingang
20.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

dosing done with the fluzone quadrivalent prefilled syringe for a 14-month-old patient, he states that two dosages were administered but not in the appropriate time frame with no reported adverse event; Initial information received on 13-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 14 months old and unknown gender patient for whom dosing done with the Influenza Quadrival A-B Vaccine [Fluzone QIV] prefilled syringe but not in the appropriate time frame with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 11-Oct and 27-Oct both in unknown year, the patient received a dose of suspect Influenza Quadrival A-B Vaccine suspension for injection (lot U8192AA for date 11-Oct and for 27-Oct the lot is U8192BA with unknown strength, dose, expiry date) via unknown route in unknown administration site as immunization not in the appropriate time frame with no reported adverse event (inappropriate schedule of product administration) (unknown latency). It was reported "the first dose was given on 11OctxxXX and the second dose was given 27OctxxXX so the dose was administered two weeks before it should have been administered and he is looking for some clinical guidance on how to proceed with the patient." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715685

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

gering
Staat
NC
Alter
11,0
Geschlecht
M
Eingang
20.11.2023
Impfdatum
17.11.2023
Beginn
17.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Pt was given the 12+ dose when he should have received the 5-11 yr dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
Nothing known
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2715683

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

gering
Staat
NC
Alter
8,0
Geschlecht
M
Eingang
20.11.2023
Impfdatum
17.11.2023
Beginn
17.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Pt was given the 12+ year dose when he should have been given the 5-11 dose...

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Nothing known
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2711225

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8192AA

gering
Staat
NV
Alter
73,0
Geschlecht
M
Eingang
07.11.2023
Impfdatum
23.10.2023
Beginn
23.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

a patient received FLUZONE QUADRIVALENT PFS, but in actuality desired to have Fluzone High-Dose PFS with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 73 years old male patient where reporter reported patient received influenza quadrival a-b vaccine [fluzone qiv] but in actuality desired to have influenza usp trival a-b high dose subvirion vaccine [fluzone high dose] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included tozinameran (Pfizer biontech covid-19 vaccine) for Prophylactic vaccination. On 23-Oct-2023, the patient received 0.5 ml dose of suspect influenza quadrival a-b vaccine Suspension for injection (lot- U8192AA and expiration date- 20-Jun-2023) via intramuscular route in the left deltoid (strength: not provided) for Immunisation (wrong product administered) (latency- same day). On an unknown date, the patient received a dose of suspect influenza usp trival a-b high dose subvirion vaccine Suspension for injection in pre-filled syringe lot number not reported via unknown route in unknown administration site (dose, strength and expiration date: not provided) for Immunisation. Action taken- not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PFIZER BIONTECH COVID-19 VACCINE
Allergien
-
Vorherige Impfungen
-